EpiPen® Auto-Injector and you - learning to live with the risk of anaphylaxis

It’s easy to feel overwhelmed if you – or your child – are at risk of anaphylaxis (severe allergic reaction); there’s so much to consider. However, there are many things you can do to reduce the risk of anaphylaxis, and with the right information and support you can feel more comfortable and confident.

The most important things to remember are:1

Always carry your EpiPen® or EpiPen® Jr Auto-Injector: If it’s with you, it could save you.2,3

Register an EpiPen®Auto-Injector

Practise with your EpiPen® Trainer and watch the ”How to use” video regularly

Watch the training video

Complete your ASCIA Anaphylaxis Action Plan and make sure it is carried with you

Download the action plan

Continue to attend appointments with your doctor or specialist for ongoing management

Daily life advice

Do your best to avoid your triggers. This means you need to learn what your triggers are, and where they might be found. Your doctor or specialist may be able to help with education on avoidance as part of your ongoing management

See common

Help is available

You can find more help and advice on living with anaphylaxis from the following organisations.

ASCIA is the peak professional body for clinical immunology and allergy in Australia and New Zealand. The ASCIA website www.allergy.org.au/anaphylaxis provides accessible, consistent and evidence based resources, education and training about anaphylaxis for health professionals, patients, carers and community.

Allergy & Anaphylaxis Australia is the peak not-for-profit organisation for those living with allergy including the risk of anaphylaxis. For trusted information and support, go to www.allergyfacts.org.au

  • References:

    1. Australasian Society of Clinical Immunology and Allergy [Internet]. Anaphylaxis; [ cited August 2020 ]. Available from: www.allergy.org.au/patients/about-allergy/anaphylaxis.
    2. EpiPen® Approved Product Information. October 2019.
    3. EpiPen® Jr Approved Product Information. October 2019.

Login to MyEpiPen®

Join more than 35,000 EpiPen® Auto-Injector users and reap the benefits1

MyEpiPen® is an online resource dedicated to helping you and your family be better prepared to manage anaphylaxis (severe allergic reaction). If you're not yet a member of MyEpiPen®, make sure you join today to receive:

  • An EpiPen®  Trainer – a training device to help you practise using EpiPen® Auto-Injector
  • How to use EpiPen® Auto-Injector fridge magnet - to serve as a useful reminder
  • Expiry reminders - to help ensure you always have an in-date EpiPen® Auto-Injector at hand
  • Regular updates on the latest anaphylaxis news

Register here

Welcome to MyEpiPen®

Patients and Carers

Our new website is designed to support Australians who have been diagnosed with
severe allergies and are at risk of anaphylaxis.


Schools and Pharmacists

We’re busy working on your new programs, and look forward to welcoming you to the
new site soon. In the meantime, please click below to access the EpiClub® site as usual.

July 2021. EPI-2021-0194.

When collecting your EpiPen® or EpiPen® Jr Auto-Injector prescription, your pharmacist may try to switch it, or talk to you about switching to Anapen®.1

EpiPen® Auto-Injectors and Anapen® are not the same:2-4

EpiPen® takes just 2 steps to use.2,3

Anapen® takes more steps.4

EpiPen® has a Never-See-Needle.™2,3

Anapen®’s needle is exposed after use.4

  • Switching means retraining: You, your family, friends and caregivers must retrain to use a different device correctly if you have an anaphylactic attack2-4
  • Switching means a different ASCIA Action Plan: You will also need to get a new ASCIA Action Plan, specific to Anapen®5

Remember, you don’t have to change. It’s your choice6
Be specific and tell your GP and pharmacist that you want your EpiPen® Auto-Injector prescription.


  1. NPS Medicinewise. Brand equivalence — ‘a’ flagging explained. Available at: https://www.nps.org.au/radar/articles/brand-equivalence-a-flagging-explained. Accessed December 2021.
  2. EpiPen® Adrenaline (epinephrine) 300 μg/0.3 mL Auto-Injector. Consumer Medicine information. July 2021.
  3. EpiPen® Jr. Adrenaline (epinephrine) 150 μg/0.3 mL Auto-Injector. Consumer Medicine information. July 2021.
  4. Anapen® Consumer Medicine information. March 2021.
  5. ASCIA Action Plans for Anaphylaxis (RED). https://www.allergy.org.au/hp/ascia-plans-action-and-treatment. Accessed December 2021.
  6. Medical Director. Active Ingredient Prescribing is coming: here’s what you need to know. https://www.medicaldirector.com/news/clinical-practice/2020/08/active-ingredient-prescribing-is-coming-heres-what-you-need-to-know. Accessed December 2021.

February 2022. EPI-2021-0567.